BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 1668410)

  • 1. MR imaging of the breast with Gd-DTPA enhancement: comparison with mammography and ultrasonography.
    Hachiya J; Seki T; Okada M; Nitatori T; Korenaga T; Furuya Y
    Radiat Med; 1991; 9(6):232-40. PubMed ID: 1668410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast disease: tissue characterization with Gd-DTPA enhancement profiles.
    Stack JP; Redmond OM; Codd MB; Dervan PA; Ennis JT
    Radiology; 1990 Feb; 174(2):491-4. PubMed ID: 2296657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Subtraction and dynamic MR images of breast cancer].
    Murakami Y; Aoki M; Harada J
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Apr; 53(4):375-86. PubMed ID: 8493070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of the breast with Gd-DTPA: use and limitations.
    Heywang SH; Wolf A; Pruss E; Hilbertz T; Eiermann W; Permanetter W
    Radiology; 1989 Apr; 171(1):95-103. PubMed ID: 2648479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent.
    Boetes C; Mus RD; Holland R; Barentsz JO; Strijk SP; Wobbes T; Hendriks JH; Ruys SH
    Radiology; 1995 Dec; 197(3):743-7. PubMed ID: 7480749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
    Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation.
    Fobben ES; Rubin CZ; Kalisher L; Dembner AG; Seltzer MH; Santoro EJ
    Radiology; 1995 Jul; 196(1):143-52. PubMed ID: 7784558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ability of subtraction and dynamic MR imaging to detect breast tumors: comparison with ultrasonography and mammography].
    Terao E; Takeuchi H; Iwamura A; Murakami Y; Harada J; Tada S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Sep; 54(10):950-7. PubMed ID: 7971186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound visualization of the breast in symptomatic patients.
    Harper P; Kelly-Fry E
    Radiology; 1980 Nov; 137(2):465-9. PubMed ID: 6254111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
    Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
    Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI.
    Flickinger FW; Allison JD; Sherry RM; Wright JC
    Magn Reson Imaging; 1993; 11(5):617-20. PubMed ID: 8345775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of phyllodes breast tumors from fibroadenomas on MRI.
    Wurdinger S; Herzog AB; Fischer DR; Marx C; Raabe G; Schneider A; Kaiser WA
    AJR Am J Roentgenol; 2005 Nov; 185(5):1317-21. PubMed ID: 16247156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign and malignant breast disease: magnetic resonance and radiofrequency pulse sequences.
    el Yousef SJ; O'Connell DM; Duchesneau RH; Smith MJ; Hubay CA; Guyton SP
    AJR Am J Roentgenol; 1985 Jul; 145(1):1-8. PubMed ID: 2988320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].
    Kuhl CK; Kreft BP; Hauswirth A; Gieseke J; Elevelt A; Reiser M; Schild HH
    Rofo; 1995 Jun; 162(6):482-91. PubMed ID: 7605960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic MR mammography: a technique for potentially reducing the biopsy rate for benign breast disease.
    Turkat TJ; Klein BD; Polan RL; Richman RH
    J Magn Reson Imaging; 1994; 4(4):563-8. PubMed ID: 7949682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined mammographic-sonographic evaluation of breast masses.
    Teixidor HS; Kazam E
    AJR Am J Roentgenol; 1977 Mar; 128(3):409-17. PubMed ID: 402833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can MR Imaging contribute in characterizing well-circumscribed breast carcinomas?
    Yoo JL; Woo OH; Kim YK; Cho KR; Yong HS; Seo BK; Kim A; Kang EY
    Radiographics; 2010 Oct; 30(6):1689-702. PubMed ID: 21071383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamic imaging with magnetic resonance in the diagnosis of breast disease].
    Ercolani P; Giovagnoni A; Giuseppetti G; Baldassarre S; De Nigris E; Amici F
    Radiol Med; 1991 Oct; 82(4):422-6. PubMed ID: 1767046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic value of preoperative contrast-enhanced MR imaging of the breast].
    Winnekendonk G; Krug B; Warm M; Göhring UJ; Mallmann P; Lackner K
    Rofo; 2004 May; 176(5):688-93. PubMed ID: 15122467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.